|
1
|
Emdad L, Qadeer ZA, Bederson LB, Kothari
HP, Uzzaman M and Germano IM: Is there a common upstream link for
autophagic and apoptotic cell death in human high-grade gliomas?
Neuro Oncol. 13:725–735. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Maucort-Boulch D, Baron MH, Pommier P,
Weber DC, Mizoe JE, Rochat J, Boissel JP, Balosso J, Tsuji H and
Amsallem E: Rationale for carbon ion therapy in high-grade glioma
based on a review and a meta-analysis of neutron beam trials.
Cancer Radiother. 14:34–41. 2010. View Article : Google Scholar
|
|
3
|
Begg AC, Stewart FA and Vens C: Strategies
to improve radiotherapy with targeted drugs. Nat Rev Cancer.
11:239–253. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Scaringi C, Enrici RM and Minniti G:
Combining molecular targeted agents and radiation therapy for
malignant gliomas. Onco Targets Ther. 6:1079–1095. 2013.
|
|
5
|
Chinnaiyan P, Won M, Wen PY, Rojiani AM,
Wendland M, Dipetrillo TA, Com BW and Mehta MP: RTOG 0913: a phase
1 study of daily everolimus (RAD001) in combination with radiation
therapy and temozolomide in patients with newly diagnosed
glioblastoma. Int J Radiat Oncol Biol Phys. 86:880–884. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang M, Herion TW, Timke C, Han N, Hauser
K, Weber KJ, Peschke P, Wirkner U, Lahn M and Huber PE: Trimodal
glioblastoma treatment consisting of concurrent radiotherapy,
temozolomide and the novel TGF-β receptor I kinase inhibitor
LY2109761. Neoplasia. 13:537–549. 2011.PubMed/NCBI
|
|
7
|
Sarkaria JN, Galanis E, Wu W, Peller PJ,
Giannini C, Brown PD, Uhm JH, McGraw S, Jaeckle KA and Buckner JC:
North central cancer treatment group phase I trial N057K of
everolimus (RAD001) and temozolomide in combination with radiation
therapy in patients with newly diagnosed glioblastoma multiforme.
Int J Radiat Oncol Biol Phys. 81:468–475. 2011. View Article : Google Scholar
|
|
8
|
Annovazzi L, Mellai M, Caldera V, Valente
G, Tessitore L and Schiffer D: mTOR, S6 and AKT expression in
relation to proliferation and apoptosis/autophagy in glioma.
Anticancer Res. 29:3087–3094. 2009.PubMed/NCBI
|
|
9
|
Dancey J: mTOR signaling and drug
development in cancer. Nat Rev Clin Oncol. 7:209–219. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee JJ, Kim BC, Park MJ, Lee YS, Kim YN,
Lee BL and Lee JS: PTEN status switches cell fate between premature
senescence and apoptosis in glioma exposed to ionizing radiation.
Cell Death Differ. 18:666–677. 2011. View Article : Google Scholar :
|
|
11
|
Gueulette J, Slabbert JP, Bischoff P,
Denis JM, Wambersie A and Jones D: Fast neutrons: Inexpensive and
reliable tool to investigate high-LET particle radiobiology. Radiat
Meas. 45:1414–1416. 2010. View Article : Google Scholar
|
|
12
|
Riccardi C and Nicoletti I: Analysis of
apoptosis by propidium iodide staining and flow cytometry. Nat
Protoc. 1:1458–1461. 2006. View Article : Google Scholar
|
|
13
|
Josset E, Burckel H, Noël G and Bischoff
P: The mTOR inhibitor RAD001 potentiates autophagic cell death
induced by temozolomide in a glioblastome cell line. Anticancer
Res. 33:1845–1851. 2013.PubMed/NCBI
|
|
14
|
Altmeyer A, Josset E, Denis JM, Gueulette
J, Slabbert J, Mutter D, Noël G and Bischoff P: The mTOR inhibitor
RAD001 augments radiation-induced growth inhibition in a
hepatocellular carcinoma cell line by increasing autophagy. Int J
Oncol. 41:1381–1386. 2012.PubMed/NCBI
|
|
15
|
Rodriguez-Lafrasse C and Balosso J: From
the carbon track to therapeutic efficiency of hadrontherapy. Cancer
Radiother. 16:16–24. 2012.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hada M and Georgakilas AG: Formation of
clustered DNA damage after high-LET irradiation: a review. J Radiat
Res. 49:203–210. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hamada N, Imaoka T, Masunaga S, Ogata T,
Okayasu R, Takahashi A, Kato TA, Kobayashi Y, Ohnishi T, Ono K,
Shimada Y and Teshima T: Recent advances in the biology of
heavy-ion cancer therapy. J Radiat Res. 51:365–383. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tsuboi K, Moritake T, Tsuchida Y, Tokuuye
K, Matsumura A and Ando K: Cell cycle checkpoint and apoptosis
induction in glioblastoma cells and fibroblasts irradiated with
carbon beam. J Radiat Res. 48:317–325. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Benzina S, Altmeyer A, Malek F, Dufour P,
Denis JM, Gueulette J and Bischoff P: High-LET radiation combined
with oxaliplatin induce autophagy in U-87 glioblastoma cells.
Cancer Lett. 264:63–70. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jiang YG, Peng Y and Koussougbo KS:
Necroptosis: a novel therapeutic target for glioblastoma. Med
Hypotheses. 76:350–352. 2011. View Article : Google Scholar
|
|
21
|
Todde V, Veenhuis M and van der Klei IJ:
Autophagy: principles and significance in health and disease.
Biochim Biophys Acta. 1792:3–13. 2009. View Article : Google Scholar
|
|
22
|
Hönscheid P, Datta K and Muders MH:
Autophagy: detection, regulation and its role in cancer and therapy
response. Int J Radiat Biol. Jun 25–2014.(Epub ahead of print).
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zois CE and Koukourakis MI:
Radiation-induced autophagy in normal and cancer cells: towards
novel cytoprotection and radio-sensitization policies? Autophagy.
5:442–450. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhuang W, Li B, Long L, Chen L, Huang Q
and Liang Z: Induction of autophagy promotes differentiation of
glioma-initiating cells and their radiosensitivity. Int J Cancer.
129:2720–2731. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dumont FJ and Bischoff P: Disrupting the
mTOR signaling network as a potential strategy for the enhancement
of cancer radiotherapy. Curr Cancer Drug Targets. 12:899–924. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bandhakavi S, Kim YM, Ro SH, Xie H,
Onsongo G, Jun CB, Kim DH and Griffin TJ: Quantitative nuclear
proteomics identifies mTOR regulation of DNA damage response. Mol
Cell Proteomics. 9:403–414. 2010. View Article : Google Scholar :
|
|
27
|
Chen H, Ma Z, Vanderwaal RP, Feng Z,
Gonzales-Suarez I, Wang J, Roti Roti JL, Gonzalo S and Zhang J: The
mTOR inhibitor rapamycin suppresses DNA double-strand break repair.
Radiat Res. 175:214–224. 2011. View
Article : Google Scholar : PubMed/NCBI
|
